Abstract
Introduction: The incidence, outcome and recovery of operatively managed pelvic ring fractures were studied from a three-year cohort of patients. No previous published studies have reviewed the factors influencing the outcome of operative stabilization on the neural function and natural recovery in these potentially devastating injuries.
Methods: This retrospective case series study of 489 referrals to a tertiary referral unit, from 1st Jan 2004 to 31st Dec 2006, identified 42 (8.6%) patients who had sustained pelvic ring injuries with associated neural injuries. Each pelvic injury was classified using the Tile and Burgess & Young classifications, neural injuries were classified as either complete or incomplete and the degree of post-operative skeletal displacement was quantified using radiographs. A mean clinical and radiographic follow up of 3.5 years was achieved and statistical analysis was performed used chi-squared (SPSS)
Results: The mean age of patients with neural injuries was 28 years, 32 (76%) were male and 37 (88%) had unstable, Tile type C, fracture patterns. The mean delay from time of injury to time of pelvic surgery was 11 days (range 3 – 42 days). Full resolution of neural symptoms was observed in 16 (38%) patients, with a mean fracture reduction of < 6mm. Incomplete improvement was observed in 11 patients and 15 patients had ongoing complete lumbosacral palsy. Patients who failed to achieve full resolution of neural function had a mean fracture or sacro-iliac joint reduction of 8.8 mm and the mean delay to surgery was 24 days.
Discussion: Pelvic ring injuries with an unstable fracture pattern are associated with a high incidence of neural injury. Accurate fracture reduction and stabilization, achieved without a prolonged delay, creates a better environment to achieve a good neural outcome. In such injuries with complete nerve palsy, delayed and suboptimal surgical reduction predicts a poor prognosis.
The abstracts were prepared by Mr Matt Costa and Mr Ben Ollivere. Correspondence should be addressed to Mr Costa at Clinical Sciences Research Institute, University of Warwick, Clifford Bridge Road, Coventry CV2 2DX, UK.
